SC
MRUS

Stempoint Capital’s Merus MRUS Stock Holding History

Stempoint Capital’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,000
Closed -$213K – 63
2024
Q1 		$213K Buy
+85,000
New +$3.45M 0.06% 50

Other funds holding MRUS

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Stempoint Capital's MRUS Position: Q3 2025 in Review

Stempoint Capital sold out of Merus (MRUS) in Q3 2025, closing a stake of 266,094 shares — an estimated $14M sold.

Stempoint Capital first reported a position in MRUS in Q4 2023 and held it in 7 quarters. The position peaked at $25.9M in Q4 2024. 268 funds tracked by Wall St. Rank hold MRUS as of Q3 2025.

  • Stempoint Capital reported no remaining Merus position as of Q3 2025 after selling out during the quarter.
  • Stempoint Capital sold 266,094 Merus shares in Q3 2025, an estimated $14M.
  • Stempoint Capital first reported a position in Merus in Q4 2023 and held it in 7 quarters.
  • Stempoint Capital's Merus position peaked at $25.9M in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Merus as of Q3 2025.

Based on Stempoint Capital's 13F filing for Q3 2025, filed 14 Nov 2025.